Philbeth Odidison, MSc- Biotechnology and bioengineering PCTU Clinical Trial Administrator Email: P.odidison@qmul.ac.ukProfileResearchProfileAs a biotechnology and bioengineering master's degree graduate with experience cancer research, Clinical trial (GXP) auditing and Regulatory compliance, I specialize in various molecular biology techniques, including mammalian cell culture, Bradford protein assay, MTT proliferation assay, GI50 drug testing, qPCR, SDS-PAGE and western blotting, ELISA, and flow cytometry. My professional journey has been marked by a solid foundation in the principles of ICH GCP, GLP, GCLP, GMP, GDP and GVP, which I gained through my experience as a trainee clinical trial auditor (GXP Auditor) and a Regulatory Affairs coordinator at the MHRA. Currently, I serve as a Clinical Trial Administrator for ChariotMS at the Barts and the London Pragmatic Clinical Trials Unit (PCTU) within the Centre for Evaluation & Methods at the Wolfson Institute of Population Health, Queen Mary University of London. In this role, I am responsible for managing the administrative aspects of clinical trials, ensuring compliance with regulatory standards, and facilitating efficient trial operations. My background also includes significant roles in external engagement and enterprise. I have contributed to clinical trial auditing, regulatory affairs, and the successful management of clinical trial protocols. This experience has honed my skills in ensuring adherence to Good Clinical Practices and regulatory requirements, crucial for maintaining the integrity and quality of clinical research. At Queen Mary University of London, I am affiliated with the Pragmatic Clinical Trials Unit, where I collaborate with a dedicated team to advance clinical research methodologies and outcomes. My work not only supports the effective execution of clinical trials but also contributes to the broader goals of improving public health through rigorous scientific evaluation and innovative research practices.ResearchResearch Interests:My research interests lie at the intersection of biotechnology, molecular biology, and clinical research methodologies. My experience in clinical trial auditing and regulatory affairs has cultivated a strong interest in the standards and practices that ensure the integrity and efficacy of clinical trials. Working at the Pragmatic Clinical Trials Unit (PCTU) within the Centre for Evaluation & Methods at the Wolfson Institute of Population Health has provided me with a unique perspective on the practical aspects of clinical trial management. This experience has fueled my interest in pragmatic trial designs that bridge the gap between controlled clinical environments and real-world medical practice.